| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/29/2009 | CN101417129A Gabapentin analogues for fibromyalgia and other related disorders |
| 04/29/2009 | CN101417118A Medicine capable of warming yang and relieving spasm and pain |
| 04/29/2009 | CN101417106A Formulation for treating hyperosteogeny and preparation method thereof |
| 04/29/2009 | CN101417103A Traditional Chinese medicine formulation for treating hyperplasia prostate |
| 04/29/2009 | CN101417097A Traditional Chinese medicine combination for treating cervical vertebra disease |
| 04/29/2009 | CN101417095A Medicine for treating arthrodynia |
| 04/29/2009 | CN101417084A Traditional Chinese medicine for treating sciatica and preparation method thereof |
| 04/29/2009 | CN101417082A Traditional Chinese medicine combination for treating rheumatic heart disease |
| 04/29/2009 | CN101417080A Traditional Chinese medicine preparation for treating rheumatic heart disease |
| 04/29/2009 | CN101417057A Traditional Chinese medicine decoction for treating rheumatic heart disease |
| 04/29/2009 | CN101417053A Wean bathing liquor capable of eliminating sputum and refrigerating |
| 04/29/2009 | CN101417051A External powder capable of activating the channels and strengthening bone |
| 04/29/2009 | CN101417036A Oral traditional Chinese medicine formulation for treating chronic rheumatoid arthritis |
| 04/29/2009 | CN101417035A Traditional Chinese medicine pill for treating rheumatoid arthritis |
| 04/29/2009 | CN101417026A Rheumatism medicine liquor |
| 04/29/2009 | CN101417020A Medicine composition capable of eliminating the mass and relieving swelling, absorbing clots and alleviating pain, preparation method and quality control method thereof |
| 04/29/2009 | CN101417019A External medicine composition with anti-inflammation, detumescence and pain-easing function |
| 04/29/2009 | CN101417013A Traditional Chinese medicine cataplasm for treating rheumatism and ostalgia and preparation method thereof |
| 04/29/2009 | CN101417008A Biberberine for injection as veterinary herb medicine composite preparation and preparation technique and use thereof |
| 04/29/2009 | CN101417004A Preparation method of animal medicine capable of refrigerating, relieving inflammation, nourishing the liver and promoting the gallbladder |
| 04/29/2009 | CN101416980A Use of oligosaccharide in preparing medicine for treating non-bacteria inflammation |
| 04/29/2009 | CN101416972A External medicine capable of preventing and treating cardiovascular disease and preparation method thereof |
| 04/29/2009 | CN101416961A Phenylpropionic acid medicine optical isomer and medical use thereof |
| 04/29/2009 | CN101416959A Use of 15-methano-substituted-andrographolide derivative in preparing anti-inflammatory ntipyretic analgesic medicine |
| 04/29/2009 | CN101416951A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416950A Preparation method of cmellia sponin controlled release tablets |
| 04/29/2009 | CN101416940A Eye sterile suspension containing loteprednol etabonate and preparation method thereof |
| 04/29/2009 | CN100482688C Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 04/29/2009 | CN100482664C 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases |
| 04/29/2009 | CN100482646C Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics |
| 04/29/2009 | CN100482638C N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors |
| 04/29/2009 | CN100482280C Highly compressible ethylcellulose for tableting |
| 04/29/2009 | CN100482278C Micro-cluster liquids and methods of making and using them |
| 04/29/2009 | CN100482276C Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 04/29/2009 | CN100482265C Medicine for treating facial neuritis and its preparing method |
| 04/29/2009 | CN100482262C Herbal pharmaceutical compositions for treating immun logical disorders |
| 04/29/2009 | CN100482259C Chinese medicine for treating cervical spondylosis |
| 04/29/2009 | CN100482257C Zuanshanfeng wind damp oil and its preparation method |
| 04/29/2009 | CN100482256C Oral medicine liquid for treating rheumatic diseases and its preparing method |
| 04/29/2009 | CN100482245C Medicine composition contg. isatis root and scutellariae glucoside |
| 04/29/2009 | CN100482241C Quickly-acting defervescence plaster used for infants and preparation method thereof |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/29/2009 | CN100482216C Use of hydroxide-releasing agents as skin permeation enhancers |
| 04/29/2009 | CN100482214C Blood circulation promoting and pain relieving bolus and its prepn |
| 04/29/2009 | CN100482210C External applied Chinese medicinal paste for treating arthralgia |
| 04/28/2009 | US7524973 4-Nitrooxybutyl 4-(2,6-Dichlorophenylamino)-thiophen-3-ylacetate; cytoprotective nitric oxide releasing nonsteroidal antiinflammatory agents; cyclooxygenase inhibitors; reduced side effects |
| 04/28/2009 | US7524949 Prevention or therapy of cardiovascular complications |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524874 Vanilloid receptor ligands and their use in treatments |
| 04/28/2009 | US7524858 Substituted pyrroline kinase inhibitors |
| 04/28/2009 | US7524852 Bicyclic pyrimidine derivatives |
| 04/28/2009 | US7524847 Inhibit Dipeptidyl peptidase-IV; 7-(2-Butynyl)-3-methyl-3,7-dihydropurine-2,6-dione; suppress degradation of Glucagon-Like Peptide-1; enhance action of incretin; facilitate insulin secretion from pancreatic beta -cells due to glucose stimulus; postchallenge hyperglycemia, improved oral glucose tolerance |
| 04/28/2009 | US7524836 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 04/28/2009 | US7524834 Antiinflammatory and antiallergic glucocorticosteroid, sterile glucocorticosteroids |
| 04/28/2009 | US7524830 Decoy-containing pharmaceutical compositions and method of using the same |
| 04/28/2009 | US7524815 Bovine or colostrum; milk, yogurt, curd, cheese, fermented milks, milk-based fermented products, ice creams, fermented cereal-based products, milk-based powders, infant formula, pet food; Osteoporosis, Paget's Disease, hypercalcemia, bone loss from arthritis, necrosis, or periodontal disease |
| 04/28/2009 | US7524679 Methods for culturing human lung mast cells and uses thereof |
| 04/28/2009 | US7524643 Nucleotide sequences coding voltage gated calcium channels (VGCC) for treating neurological and cardiovascular disorders; anticonvulsant |
| 04/28/2009 | US7524502 Modified anti-TNF alpha antibody |
| 04/28/2009 | US7524484 Delivery of diphenhydramine through an inhalation route |
| 04/28/2009 | CA2499330C New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 04/28/2009 | CA2446944C Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use |
| 04/28/2009 | CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/28/2009 | CA2219988C Cd16-ii variants |
| 04/28/2009 | CA2164838C A lotion comprising a tricyclic macrolide |
| 04/28/2009 | CA2155833C Photodynamic treatment of synovium |
| 04/23/2009 | WO2009052310A1 A3 adenosine receptor antagonists |
| 04/23/2009 | WO2009051824A2 Combination analgesic employing opioid and neutral antagonist |
| 04/23/2009 | WO2009051504A1 Benzo- and pyridopyridazinones with analgesic and antiinflammatory activity |
| 04/23/2009 | WO2009051244A1 Heterocyclic compound |
| 04/23/2009 | WO2009050348A1 Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 04/23/2009 | WO2009050237A1 Cgrp antagonists |
| 04/23/2009 | WO2009050235A1 Cgrp antagonists |
| 04/23/2009 | WO2009050234A1 Cgrp antagonists |
| 04/23/2009 | WO2009050232A1 Cgrp antagonists |
| 04/23/2009 | WO2009050204A1 Quinoline derivatives used to treat inflammatory and allergic diseases |
| 04/23/2009 | WO2009050198A2 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 04/23/2009 | WO2009050185A1 1,3,5-trisubstituted triazole derivative |
| 04/23/2009 | WO2009050159A1 Combination of fluticasone furoate with 4- [ (4-chl0r0phenyl)methyl] -2- ({ (2r)-i- [4-(4-{ [3-(hexahydr0-lh-azepin-l-yl) propyl ] oxy} phenyl) butyl] -2-pyrrolidinyl}methyl) -1 (2h) - phthalaz inone |
| 04/23/2009 | WO2009049961A2 New no-donor aspirin derivatives |
| 04/23/2009 | WO2009049405A1 Bilayer composition for the sustained release of acetaminophen and tramadol |
| 04/23/2009 | WO2009049370A1 Novel sulfated oligosaccharide derivatives |
| 04/23/2009 | WO2009049362A1 A1 adenosine receptor allosteric enhancers |
| 04/23/2009 | WO2009018389A4 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same |
| 04/23/2009 | WO2009015164A3 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 04/23/2009 | WO2009004171A3 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof |
| 04/23/2009 | US20090105694 Medical or veterinary digestive tract utilization systems and methods |
| 04/23/2009 | US20090105478 Novel compounds |
| 04/23/2009 | US20090105321 useful for the treatment of EP4 mediated diseases or conditions, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis, cancer and glaucoma; 4-[(1S)-1-({[1-(3-chlorobenzyl)-2,3-dihydro-1H-indol-7-yl]carbonyl}amino)ethyl]benzoic acid |
| 04/23/2009 | US20090105319 Naphthalene-based inhibitors of anti-apoptotic proteins |
| 04/23/2009 | US20090105317 VEGF Inhibition |
| 04/23/2009 | US20090105306 Novel compounds as cannabinoid receptor ligands |
| 04/23/2009 | US20090105291 Ethyl (2S)-2-[(4,4-dimethyl-3-oxo-1-cyclobutenyl)amino]-3-[(4-([2,7]naphthyridin-1-yloxy)phenyl]propanoate; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/23/2009 | US20090105281 Methods of treating inflammation |
| 04/23/2009 | US20090105243 for treating p38 kinase-associated conditions like inflammatory disorders; improved dissolution rate and oral bioavailability; rheumatic diseases; skin disorders; multiple sclerosis; osteoporosis; Alzheimer's disease |
| 04/23/2009 | US20090105242 Triazolopyridine compounds useful for the treatment of degenerative & inflammatory diseases |
| 04/23/2009 | US20090105230 Anti-inflammatory medicaments |
| 04/23/2009 | US20090105225 2-Substituted 4-Benzylphthalazinone Derivatives as Histamine H1 and H3 Antagonists |
| 04/23/2009 | US20090105217 2-phenyl-5-amino-1,3,4-oxadiazoles and their use as nicotinic acetylcholine receptor ligands |
| 04/23/2009 | US20090105216 3- (aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |